Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05731557 · ClinicalTrials.gov registry record

ACE, Resilience, and Substance Use Disorder: Maternal and Baby Outcomes in the First Year of Life

A clinical trial of Adverse Childhood Experiences, sponsored by The Cooper Health System.

Completed
Registry status
120
Enrollment target
1
Study location

NCT05731557 is a study of Adverse Childhood Experiences that has completed, run by The Cooper Health System. The registered enrollment target is 120 participants, below the 321-participant average among 13 other Adverse Childhood Experiences trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05731557, a study of Adverse Childhood Experiences, has completed, sponsored by The Cooper Health System.

COMPLETED
Registry status
120 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to understand maternal factors, including ACE and 7Cs Tool scores, and how they contribute to the health of mothers and their infant. The study will evaluate whether or not the outcomes of maternal and baby health can be identified early through the Adverse Childhood Experiences (ACE) questionnaire, 7Cs Tool questionnaire, and Maternal Health Questionnaire. Additionally, the study will ask questions regarding current maternal social factors that could influence labor and delivery.

Study Locations (1)

New Jersey

  • Cooper University Hospital - Camden

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2020-08-03
Est. Completion 2024-10-05

Sponsor

The Cooper Health System

39 total trials

What the Registry Record Tells You About NCT05731557

The ClinicalTrials.gov registry entry for NCT05731557 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 321-participant average among 13 other Adverse Childhood Experiences trials with a reported enrollment target (63% lower). The listed sponsor is The Cooper Health System, which has 39 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Adverse Childhood Experiences appearing as the primary indexed condition, and to 0 interventions.

NCT05731557 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT05731557 about?

NCT05731557 is a clinical study titled "ACE, Resilience, and Substance Use Disorder: Maternal and Baby Outcomes in the First Year of Life". The purpose of this study is to understand maternal factors, including ACE and 7Cs Tool scores, and how they contribute to the health of mothers and their infant. The study will evaluate whether or not the outcomes of maternal and baby health can be identified early through the Adverse Childhood Exp...

What is the current status of trial NCT05731557?

This trial is currently completed. The enrollment target is 120 participants. The study started on 2020-08-03. Estimated completion is 2024-10-05.

What conditions does trial NCT05731557 study?

This clinical trial studies the following conditions: Adverse Childhood Experiences.

Who is sponsoring clinical trial NCT05731557?

This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05731557 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Adverse Childhood Experiences

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.